United States Oncology Market Outlook to 2025

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4995
Buy Report

Published: March 30, 2020 Report Code: GDMECC4882DB-ST

Select Item

GlobalData’s “United States Oncology Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – ALK Tests, BRCA Tests, Colorectal Cancer Screening Tests, EGFR Tests, HER2 Amplification Tests and KRAS Tests.

The United States Oncology Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2018 company share and distribution share data for Oncology Market.
• Global corporate-level profiles of key companies operating within the United States Oncology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Oncology Tests is segmented as follows:

• ALK Tests

• BRCA Tests

• Colorectal Cancer Screening Tests

• EGFR Tests

• HER2 Amplification Tests

• KRAS Tests

Reasons to Buy

Key Reasons to Purchase – The United States Oncology Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “United States Oncology Market Outlook to 2025” report:
• Exact Sciences Corp
• Abbott Laboratories
• F. Hoffmann-La Roche Ltd

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 6

2.1 What Is This Report About? 6

2.2 Oncology Market Segmentation 6

2.3 Definitions of Markets Covered in the Report 7

3 Oncology Market, United States 12

3.1 Oncology Market, United States, Revenue ($m), 2015-2025 12

3.1.1 ALK Tests Market, United States, Revenue ($m), by Segment, 2015-2025 15

3.1.2 BRCA Tests Market, United States, Revenue ($m), by Segment, 2015-2025 17

3.1.3 Colorectal Cancer Screening Tests Market, United States, Revenue ($m), by Segment, 2015-2025 19

3.1.4 EGFR Tests Market, United States, Revenue ($m), by Segment, 2015-2025 22

3.1.5 HER2 Amplification Tests Market, United States, Revenue ($m), by Segment, 2015-2025 25

3.1.6 KRAS Tests Market, United States, Revenue ($m), by Segment, 2015-2025 27

3.2 Oncology Market, United States, Volume (Units), 2015-2025 29

3.2.1 ALK Tests Market, United States, Volume (Units), by Segment, 2015-2025 32

3.2.2 BRCA Tests Market, United States, Volume (Units), by Segment, 2015-2025 34

3.2.3 Colorectal Cancer Screening Tests Market, United States, Volume (Units), by Segment, 2015-2025 36

3.2.4 EGFR Tests Market, United States, Volume (Units), by Segment, 2015-2025 39

3.2.5 HER2 Amplification Tests Market, United States, Volume (Units), by Segment, 2015-2025 42

3.2.6 KRAS Tests Market, United States, Volume (Units), by Segment, 2015-2025 44

3.3 Oncology Market, United States, Average Price ($), 2015-2025 46

3.4 Oncology Market, United States, Distribution Share by Revenue ($m), 2018 50

3.5 Oncology Market, United States, Company Share by Revenue ($m), 2018 51

4 Overview of Key Companies in United States, Oncology Market 53

4.1 Exact Sciences Corp 53

4.1.1 Company Overview 53

4.2 Abbott Laboratories 53

4.2.1 Company Overview 53

4.3 F. Hoffmann-La Roche Ltd 53

4.3.1 Company Overview 53

4.4 Qiagen NV 53

4.4.1 Company Overview 53

4.5 Thermo Fisher Scientific Inc 54

4.5.1 Company Overview 54

4.6 Agilent Technologies Inc 54

4.6.1 Company Overview 54

4.7 Danaher Corp 54

4.7.1 Company Overview 54

5 Financial Deals Landscape 55

5.1 Merger 55

5.1.1 Navaux Merges with Stage I Diagnostics 55

5.2 Partnerships 56

5.2.1 Lexent Bio Enters into Partnership Agreement with Illumina 56

5.2.2 Natera and Foundation Medicine Enter into Partnership 57

5.2.3 Progenics Pharma Enters into Research Collaboration Agreement with VA Greater Los Angeles Healthcare System 59

5.2.4 Breath Diagnostics and Mayo Clinic Laboratories Enter into Collaboration 60

5.3 Private Equity 61

5.3.1 Seacoast Capital Invests USD30 Million in SkinCure Oncology 61

5.4 Venture Financing 62

5.4.1 GenomOncology Raises USD1.4 Million in Venture Financing 62

5.4.2 Apostle Raises USD3.3 Million in Series A Financing 63

6 Recent Developments 64

6.1 Other Significant Developments 64

6.1.1 Oct 18, 2019: Ochsner Health System to pilot genetic screening program in partnership with Color 64

6.1.2 Sep 09, 2019: Liquid biopsies reveal genetic alterations linked to cancer drug resistance 65

6.1.3 May 23, 2019: New approach captures detailed mid-infrared images for medical diagnostics 66

6.2 Product News 67

6.2.1 Jul 25, 2019: AI tool identifies cancer outcomes using radiology reports 67

6.2.2 Jul 19, 2019: Infrared chemical imaging technology promises new precision cancer diagnosis 68

6.2.3 Jun 06, 2019: Caris Life Sciences' Precision Oncology Alliance publishes new review of molecular testing in cancer 68

6.3 Research And Development 69

6.3.1 Oct 21, 2019: UK-US alliance launched to boost early cancer detection rates 69

6.4 Strategy And Business Planning 70

6.4.1 Oct 09, 2019: Qiagen and Illumina sign 15-year deal for IVD tests 70

6.4.2 Sep 16, 2019: Varian to invest in Oncora to develop radiation oncology tools 70

6.4.3 Aug 01, 2019: Inspirata and Fujifilm strike commercial partnership to supply digital pathology services to the UK National Health Service 71

7 Appendix 72

7.1 Research Methodology 73

7.1.1 Coverage 73

7.1.2 Secondary Research 73

7.1.3 Primary Research 74

7.1.4 Market Modeling and Forecasting 75

7.1.5 Company Share Analysis 76

7.1.6 Distribution Share Analysis 77

7.1.7 Benchmarking 77

7.2 GlobalData Consulting 77

7.3 Contact Us 78

7.4 Disclaimer 78

Table

1.1 List of Tables

Table 1: Oncology Market, United States, Revenue ($m), USD Constant, 2015-2020 13

Table 2: Oncology Market, United States, Revenue ($m), USD Constant, 2021-2025 14

Table 3: ALK Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 16

Table 4: ALK Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 16

Table 5: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 18

Table 6: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 18

Table 7: Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 20

Table 8: Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 21

Table 9: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 23

Table 10: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 24

Table 11: HER2 Amplification Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 26

Table 12: HER2 Amplification Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 26

Table 13: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2015-2020 28

Table 14: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2021-2025 28

Table 15: Oncology Market, United States, Volume (Units), 2015-2020 30

Table 16: Oncology Market, United States, Volume (Units), 2021-2025 31

Table 17: ALK Tests Market, United States, Volume (Units), 2015-2020 33

Table 18: ALK Tests Market, United States, Volume (Units), 2021-2025 33

Table 19: BRCA Tests Market, United States, Volume (Units), 2015-2020 35

Table 20: BRCA Tests Market, United States, Volume (Units), 2021-2025 35

Table 21: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2015-2020 37

Table 22: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2021-2025 38

Table 23: EGFR Tests Market, United States, Volume (Units), 2015-2020 40

Table 24: EGFR Tests Market, United States, Volume (Units), 2021-2025 41

Table 25: HER2 Amplification Tests Market, United States, Volume (Units), 2015-2020 43

Table 26: HER2 Amplification Tests Market, United States, Volume (Units), 2021-2025 43

Table 27: KRAS Tests Market, United States, Volume (Units), 2015-2020 45

Table 28: KRAS Tests Market, United States, Volume (Units), 2021-2025 45

Table 29: Oncology Market, United States, Average Price ($), 2015-2020 46

Table 30: Oncology Market, United States, Average Price ($), 2021-2025 48

Table 31: Oncology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 50

Table 32: Oncology Market, United States, Company Share by Revenue ($m), USD Constant, 2018 52

Table 33: Navaux Merges with Stage I Diagnostics 55

Table 34: Lexent Bio Enters into Partnership Agreement with Illumina 56

Table 35: Natera and Foundation Medicine Enter into Partnership 57

Table 36: Progenics Pharma Enters into Research Collaboration Agreement with VA Greater Los Angeles Healthcare System 59

Table 37: Breath Diagnostics and Mayo Clinic Laboratories Enter into Collaboration 60

Table 38: Seacoast Capital Invests USD30 Million in SkinCure Oncology 61

Table 39: GenomOncology Raises USD1.4 Million in Venture Financing 62

Table 40: Apostle Raises USD3.3 Million in Series A Financing 63

Table 41: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 75

Figures

1.2 List of Figures

Figure 1: Oncology Market, United States, Revenue ($m), USD Constant, 2015-2025 12

Figure 2: ALK Tests Market, United States, Revenue ($m), USD Constant, 2015-2025 15

Figure 3: BRCA Tests Market, United States, Revenue ($m), USD Constant, 2015-2025 17

Figure 4: Colorectal Cancer Screening Tests Market, United States, Revenue ($m), USD Constant, 2015-2025 19

Figure 5: EGFR Tests Market, United States, Revenue ($m), USD Constant, 2015-2025 22

Figure 6: HER2 Amplification Tests Market, United States, Revenue ($m), USD Constant, 2015-2025 25

Figure 7: KRAS Tests Market, United States, Revenue ($m), USD Constant, 2015-2025 27

Figure 8: Oncology Market, United States, Volume (Units), 2015-2025 29

Figure 9: ALK Tests Market, United States, Volume (Units), 2015-2025 32

Figure 10: BRCA Tests Market, United States, Volume (Units), 2015-2025 34

Figure 11: Colorectal Cancer Screening Tests Market, United States, Volume (Units), 2015-2025 36

Figure 12: EGFR Tests Market, United States, Volume (Units), 2015-2025 39

Figure 13: HER2 Amplification Tests Market, United States, Volume (Units), 2015-2025 42

Figure 14: KRAS Tests Market, United States, Volume (Units), 2015-2025 44

Figure 15: Oncology Market, United States, Company Share (%) 2018 51

Frequently asked questions

United States Oncology Market Outlook to 2025 standard reports
Currency USD
$4,995

Can be used by individual purchaser only

Most Popular
$9,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$14,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States Oncology Market Outlook to 2025 in real time.

  • Access a live United States Oncology Market Outlook to 2025 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more